Magnetic resonance imaging findings in AIDS patients with central nervous system cryptococcosis

Marcelo Corti1, Maria Florencia Villafañe, Ricardo Negroni

  • 1Division of HIV/AIDS Disease, F. J. Muñiz Hospital, Buenos Aires, Argentina. marcelocorti@fibertel.com.ar

Insights

Neurocryptococcosis, a fungal infection by Cryptococcus neoformans, commonly affects the central nervous system in AIDS patients. This study details five cases with parenchymal lesions like gelatinous pseudocysts and cryptococcomas.

Area of Science:

  • Mycology
  • Neurology
  • Infectious Diseases

Background:

  • Cryptococcosis is an opportunistic fungal infection caused by Cryptococcus neoformans.
  • Central nervous system (CNS) involvement is common, particularly in individuals with human immunodeficiency virus (HIV) infection.
  • CNS lesions can manifest as meningeal or parenchymal, with parenchymal lesions including gelatinous pseudocysts and cryptococcomas.

Purpose of the Study:

  • To describe five cases of neurocryptococcosis in patients with acquired immunodeficiency syndrome (AIDS).
  • To characterize the parenchymal lesions, specifically gelatinous pseudocysts and cryptococcomas, associated with neurocryptococcosis in this patient population.

Main Methods:

  • Case series describing five patients with neurocryptococcosis.
  • Clinical and radiological findings of CNS lesions were analyzed.
  • Histopathological correlation was performed where available.

Main Results:

  • Five patients with AIDS and neurocryptococcosis were identified.
  • Parenchymal lesions consistent with gelatinous pseudocysts and cryptococcomas were observed in these patients.
  • The characteristic dilatation of Virchow-Robin spaces filled with mucoid material was noted.

Conclusions:

  • Neurocryptococcosis in AIDS patients can present with distinct parenchymal lesions.
  • Gelatinous pseudocysts and cryptococcomas are significant manifestations of CNS cryptococcosis.
  • Understanding these lesions is crucial for diagnosis and management of neurocryptococcosis in immunocompromised individuals.